Neutra (NTRR), a provider of all-natural wellness solutions, has initiated the development activities for a new oral delivery system for nutraceuticals including medical marijuana.
Dr Richard Kaufman has been hired by Neutra to oversee the development of the new nutraceutical delivery system.
Neutra is close to wrapping a joint venture pact with Second Wave Ventures, a developer of cannabinoid products infused with healthy nutrients, for developing new methods of smokeless THC and CBD delivery.
THC-rich cannabis and CBD found in medical marijuana reduced the onset of neuropathy, and provided relief from chronic pain due to muscle spasticity, muscle convulsions and inflammation respectively in recently held FDA trials.
Neutra is also working with Cannabis Technologies in bringing more healthier and efficient delivery systems for nutraceuticals, including medical marijuana.
The company hopes to penetrate the medical marijuana markets by achieving technological breakthroughs in the delivery of Cannabinoids found in medical marijuana.
